i-SENS, Inc. (099190.KQ)
KRW 16060.0
(-3.37%)
KRW 16060.0
(-3.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 83.54 Billion KRW | 3.52% |
| 2022 | 80.69 Billion KRW | 59.33% |
| 2021 | 50.64 Billion KRW | 47.02% |
| 2020 | 34.45 Billion KRW | 8.77% |
| 2019 | 31.67 Billion KRW | 3.68% |
| 2018 | 30.54 Billion KRW | 5.0% |
| 2017 | 29.09 Billion KRW | -7.92% |
| 2016 | 31.59 Billion KRW | 50.07% |
| 2015 | 21.05 Billion KRW | -0.32% |
| 2014 | 21.12 Billion KRW | -2.71% |
| 2013 | 21.71 Billion KRW | 58.6% |
| 2012 | 13.68 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 81.17 Billion KRW | 0.08% |
| 2024 Q1 | 81.11 Billion KRW | -2.91% |
| 2023 Q4 | 83.54 Billion KRW | -6.02% |
| 2023 Q1 | 80.21 Billion KRW | -0.59% |
| 2023 Q2 | 78.85 Billion KRW | -1.7% |
| 2023 FY | 83.54 Billion KRW | 3.52% |
| 2023 Q3 | 88.89 Billion KRW | 12.73% |
| 2022 FY | 80.69 Billion KRW | 59.33% |
| 2022 Q1 | 54.87 Billion KRW | 8.34% |
| 2022 Q3 | 77.95 Billion KRW | 14.58% |
| 2022 Q4 | 80.69 Billion KRW | 3.52% |
| 2022 Q2 | 68.02 Billion KRW | 23.97% |
| 2021 FY | 50.64 Billion KRW | 47.02% |
| 2021 Q1 | 37.73 Billion KRW | 9.54% |
| 2021 Q2 | 41.21 Billion KRW | 9.22% |
| 2021 Q4 | 50.64 Billion KRW | 7.62% |
| 2021 Q3 | 47.06 Billion KRW | 14.18% |
| 2020 Q1 | 32.28 Billion KRW | 1.94% |
| 2020 Q3 | 37.38 Billion KRW | 4.72% |
| 2020 FY | 34.45 Billion KRW | 8.77% |
| 2020 Q4 | 34.45 Billion KRW | -7.85% |
| 2020 Q2 | 35.7 Billion KRW | 10.57% |
| 2019 Q1 | 33.1 Billion KRW | 8.37% |
| 2019 FY | 31.67 Billion KRW | 3.68% |
| 2019 Q3 | 33.77 Billion KRW | -0.14% |
| 2019 Q2 | 33.82 Billion KRW | 2.16% |
| 2019 Q4 | 31.67 Billion KRW | -6.22% |
| 2018 Q4 | 30.54 Billion KRW | -6.89% |
| 2018 Q1 | 32.02 Billion KRW | 10.06% |
| 2018 Q2 | 31.21 Billion KRW | -2.51% |
| 2018 FY | 30.54 Billion KRW | 5.0% |
| 2018 Q3 | 32.8 Billion KRW | 5.1% |
| 2017 Q4 | 29.09 Billion KRW | -11.15% |
| 2017 Q3 | 32.74 Billion KRW | 3.47% |
| 2017 Q1 | 30.25 Billion KRW | -4.24% |
| 2017 FY | 29.09 Billion KRW | -7.92% |
| 2017 Q2 | 31.64 Billion KRW | 4.6% |
| 2016 Q3 | 28.27 Billion KRW | 12.31% |
| 2016 FY | 31.59 Billion KRW | 50.07% |
| 2016 Q4 | 31.59 Billion KRW | 11.75% |
| 2016 Q2 | 25.17 Billion KRW | 17.41% |
| 2016 Q1 | 21.44 Billion KRW | 1.84% |
| 2015 Q2 | 19.03 Billion KRW | -5.55% |
| 2015 FY | 21.05 Billion KRW | -0.32% |
| 2015 Q1 | 20.15 Billion KRW | -4.6% |
| 2015 Q4 | 21.05 Billion KRW | 10.07% |
| 2015 Q3 | 19.12 Billion KRW | 0.51% |
| 2014 Q3 | 19.74 Billion KRW | 1.39% |
| 2014 FY | 21.12 Billion KRW | -2.71% |
| 2014 Q2 | 19.47 Billion KRW | -8.08% |
| 2014 Q4 | 21.12 Billion KRW | 6.98% |
| 2014 Q1 | 21.18 Billion KRW | -2.42% |
| 2013 Q1 | 14.41 Billion KRW | 5.33% |
| 2013 Q3 | 19.57 Billion KRW | 21.22% |
| 2013 Q4 | 21.71 Billion KRW | 10.93% |
| 2013 Q2 | 16.14 Billion KRW | 11.97% |
| 2013 FY | 21.71 Billion KRW | 58.6% |
| 2012 FY | 13.68 Billion KRW | 0.0% |
| 2012 Q4 | 13.68 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 15.04 Billion KRW | -455.16% |
| InBody Co.,Ltd | 29.41 Billion KRW | -183.975% |
| Curexo Inc. | 31.77 Billion KRW | -162.943% |
| Seegene, Inc. | 137.63 Billion KRW | 39.303% |
| Ray Co., Ltd. | 25.37 Billion KRW | -229.268% |
| Gencurix Inc. | 581.02 Million KRW | -14278.146% |
| Sugentech Inc. | 7.01 Billion KRW | -1090.096% |
| L&C Bio Co., Ltd | 46.28 Billion KRW | -80.48% |